Concert Pharmaceuticals
$8.37
12
+$0.01+0.12% Friday 21:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
401.24M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
6NovExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-65.45%Profit Margin
Unprofitable32.59MRevenue
-21.33MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CNCE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Show more...
CEO
Roger Tung
Employees
64
Country
United States
ISIN
US2060221056
WKN
000A1XEAC
Listings
0 Comments
Share your thoughts
FAQ
What is Concert Pharmaceuticals stock price today?▼
The current price of CNCE is $8.37 USD — it has increased by +0.12% in the past 24 hours. Watch Concert Pharmaceuticals stock price performance more closely on the chart.
What is Concert Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Concert Pharmaceuticals stocks are traded under the ticker CNCE.
What is Concert Pharmaceuticals market cap?▼
Today Concert Pharmaceuticals has the market capitalization of 401.24M
What is Concert Pharmaceuticals revenue for the last year?▼
Concert Pharmaceuticals revenue for the last year amounts to 32.59M USD.
What is Concert Pharmaceuticals net income for the last year?▼
CNCE net income for the last year is -21.33M USD.
How many employees does Concert Pharmaceuticals have?▼
As of April 17, 2026, the company has 64 employees.
In which sector is Concert Pharmaceuticals located?▼
Concert Pharmaceuticals operates in the Manufacturing sector.
When did Concert Pharmaceuticals complete a stock split?▼
Concert Pharmaceuticals has not had any recent stock splits.
Where is Concert Pharmaceuticals headquartered?▼
Concert Pharmaceuticals is headquartered in Lexington, United States.